Skip to content
pharmanlifescience
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
Subscribe
Nordson

With an $800M Investment, Nordson will Acquire Atrion and its Medical Infusion Fluid Delivery Systems

Nordson officials announced that it has reached a deal to pay roughly $800 million to

Read More »
« Previous Page1 … Page3 Page4 Page5 Next »
pharmanlifescience
Pharmanlifescience transcends ordinary magazines, serving as a vibrant hub for collaboration and knowledge exchange within the dynamic life sciences arena …..Read More

© 2025 PHARMANLIFESCIENCE. All Rights Reserved

Quick Links

  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us
  • Home
  • About Us
  • Magazines
  • Articles
    • Research & Development
    • Global Health Perspectives
    • Biotechnology & Innovations
    • Healthcare & Therapeutics
    • Pharmaceutical Manufacturing
  • News
  • Contact Us

Latest Posts

Pfizer to Sell $3 Billion Stake in Haleon Reducing Ownership to 7.3%

Pfizer to Sell $3 Billion Stake in Haleon Reducing Ownership to 7.3%

Eli Lilly to Acquire Scorpion Therapeutics’ Cancer Therapy for Up to $2.5 Billion

Eli Lilly to Acquire Scorpion Therapeutics’ Cancer Therapy for Up to $2.5 Billion

Telix Pharmaceuticals Acquires ImaginAb for $73 Million to Expand Antibody Engineering Capabilities

Telix Pharmaceuticals Acquires ImaginAb for $73 Million to Expand Antibody Engineering Capabilities

DBAY Advisors to Acquire Alliance Pharma in $430 Million All-Cash Deal

DBAY Advisors to Acquire Alliance Pharma in $430 Million All-Cash Deal